Great West Life Assurance CO Precision Biosciences Inc Transaction History

Great West Life Assurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.15 - $3.34 $4,373 - $12,702	-3,803 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.96 - $7.76 $2,587 - $6,782	874 Added 29.84%	3,803 $12,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $6,267 - $9,876	847 Added 40.68%	2,929 $21,000
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $24,150 - $44,496	-2,818 Reduced 57.51%	2,082 $21,000
Q2 2020 Aug 17, 2020	BUY	$4.66 - $8.7 $22,834 - $42,630	4,900 New	4,900 $41,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $526M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.